Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Brain Inj ; 28(11): 1436-40, 2014.
Article in English | MEDLINE | ID: mdl-24950253

ABSTRACT

BACKGROUND: Epidemiology of severe traumatic brain injury (TBI) is poorly defined in the Pacific region, including in New Caledonia. The aim of this study was to assess the incidence, causes and outcome of hospital-admitted severe TBI in the whole population of New Caledonia. METHODS: A retrospective study on patients with severe TBI admitted to the only trauma centre during the 5-year period (2008-2012) was performed. The electronic patient register was searched for diagnoses of intracranial injuries to identify patients. Severe TBI was defined as a Glasgow Coma Scale Score ≤ 8 during the first 24 hours after injury. RESULTS: The annual incidence ranged from 10/100 000 in 2010 to 15/100 000 in 2011. Road traffic accidents (n = 109; 71%), falls (n = 26; 17%) and assaults (n = 19; 12%) were causes of severe TBI. Young Melanesian adults (median age = 26 [19-36]) were the most affected. In ICU, the overall case-fatality rate was 25%. The mortality rate was the highest among victims of assaults (47%). CONCLUSIONS: The high incidence of hospital-admitted patients with severe TBI in this study combined with high in-ICU mortality rates supports the need for targeted public health action to prevent assaults and traffic road accidents in this vulnerable population.


Subject(s)
Accidents, Traffic/statistics & numerical data , Brain Injuries/epidemiology , Hospital Mortality , Hospitalization/statistics & numerical data , Trauma Centers , Violence/statistics & numerical data , Accidents, Traffic/mortality , Adolescent , Adult , Age Distribution , Brain Injuries/mortality , Brain Injuries/therapy , Critical Care/statistics & numerical data , Ethnicity , Female , Glasgow Coma Scale , Health Services Needs and Demand , Humans , Incidence , Injury Severity Score , Male , Middle Aged , Pacific Islands/epidemiology , Registries , Retrospective Studies , Sex Distribution
2.
Can J Anaesth ; 56(2): 102-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19247757

ABSTRACT

BACKGROUND: Septorhinoplasty is a traumatic procedure that is associated with epistaxis and postoperative pain. The primary objective of this randomized double-blind controlled trial was to determine whether intranasal 5% lidocaine plus naphazoline decreases postoperative pain and lessens the use of rescue analgesics. METHODS: After induction of general anesthesia and laryngeal topical anesthesia with 5% lidocaine, 28 adult patients, scheduled to undergo septorhinoplasty, were randomly assigned to one of two groups, either topical intranasal saline 20 ml (control group) or intranasal 5% lidocaine plus naphazoline solution 0.2 mg ml(-1) (lidocaine group). The perioperative dose of sufentanil, the mean end-tidal concentration of isoflurane, and surgeon satisfaction with the operative field were recorded. In the lidocaine group, plasma lidocaine concentrations were sampled 15, 20, 25, 35, 45, and 55 min after induction of anesthesia. Visual analogue scale pain scores were recorded 30, 60, 90, and 120 min after the patients arrived in the postanesthesia care unit and 24 h after surgery. Consumption of morphine rescue analgesia and the occurrence of any side effects were recorded at the end of the 24-h study period. RESULTS: The intranasal lidocaine-naphazoline application decreased isoflurane requirements [median values: 0.8% (0.7-1.5) vs. 1.2% (0.9-1.8), respectively; P = 0.04] and enhanced surgical conditions. Patients in the lidocaine group experienced less postoperative pain than the control group [1 h after surgery: median values of visual analogue scale: 0 (0-20) vs. 50 (30-80), respectively; P = 0.001], and they required fewer doses of subcutaneous morphine. Total plasma concentrations of lidocaine remained below 4 microg ml(-1) throughout the study period. CONCLUSIONS: Intranasal lidocaine plus naphazoline is a simple and efficient technique for decreasing intra- and postoperative pain and for lessening rescue analgesic requirements in the postoperative period after septorhinoplasty. Toxic plasma concentrations of lidocaine were not reached.


Subject(s)
Anesthetics, Local/administration & dosage , Lidocaine/administration & dosage , Naphazoline/administration & dosage , Pain, Postoperative/prevention & control , Administration, Intranasal , Adolescent , Adult , Analgesics, Opioid/administration & dosage , Anesthetics, Inhalation/administration & dosage , Anesthetics, Local/pharmacokinetics , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Lidocaine/pharmacokinetics , Male , Middle Aged , Morphine/administration & dosage , Nasal Decongestants/administration & dosage , Nasal Septum/surgery , Perioperative Care/methods , Rhinoplasty/methods , Young Adult
3.
Anesth Analg ; 94(6): 1606-13, table of contents, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12032037

ABSTRACT

UNLABELLED: A computed tomographic scan was obtained in 35 patients to measure the depth and the relationship of the branches of the lumbar plexus to the posterior superior iliac spine projection and the vertebral column. In addition, we prospectively studied 80 patients scheduled for total hip arthroplasty who received a continuous psoas compartment block (CPCB) in the postoperative period. CPCB was performed after surgical procedures by using modified Winnie's landmarks and nerve stimulation. From 5 to 8 cm of catheter was inserted. Radiographs were obtained after injection of 10 mL of contrast medium. An initial loading dose (0.4 mL/kg) of 0.2% ropivacaine was injected, followed by continuous infusion of 0.2% ropivacaine for 48 h. The depth of the lumbar plexus and the distance between the lumbar plexus and the L4 transverse process were measured. Visual analog scale values of pain at 1, 12, 24, and 48 h were obtained at rest and during mobilization. Amounts of rescue analgesia were also recorded. Sensory blockade of the principal branches of the lumbosacral plexus was noted at 1 and 24 h, as were adverse events related to the technique. There was a significant difference between men and women in depth of the lumbar plexus (median values, 85 vs 70 mm for men and women, respectively). There was a positive correlation between the body mass index and skin-lumbar plexus distances. In contrast, there was no difference regarding the distance between the transverse process of L4 and the lumbar plexus. The catheter tip lay within the psoas major muscle in 74% of the patients and between the psoas and quadratus lumborum muscles in 22%. In three patients, the catheter was improperly positioned. At 1 h, sensory blockade of the femoral, obturator, and lateral femoral cutaneous nerves was successful in, respectively, 95%, 90%, and 85% of patients. At 24 h, these rates were 88%, 88%, and 83%, respectively. During the 48-h study period, median visual analog scale values of pain were approximately 10 mm at rest and from 18 to 25 mm during physiotherapy. Five patients received 5 mg of morphine at 1 h. Five cases of unilateral epidural anesthesia were noted after the bolus injection. We conclude that CPCB with 0.2% ropivacaine allows optimal analgesia after hip arthroplasty, with few side effects and a small failure rate. Before lumbar plexus branch stimulation and catheter insertion, anesthesiologists should be aware of the L4 transverse process location and lumbar plexus depth. IMPLICATIONS: Lumbar plexus depth is correlated with the patient's body mass index and differs between men and women, but this is not true of the lumbar plexus-transverse process distance. Considering new landmarks, a continuous psoas compartment block promotes optimal analgesia after hip arthroplasty, with few side effects.


Subject(s)
Analgesia , Arthroplasty, Replacement, Hip , Nerve Block , Pain, Postoperative/drug therapy , Psoas Muscles/physiology , Adult , Aged , Aged, 80 and over , Amides , Anesthetics, Local , Double-Blind Method , Female , Fluoroscopy , Hip/diagnostic imaging , Humans , Male , Middle Aged , Monitoring, Intraoperative , Pain Measurement , Ropivacaine , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL